prostate cancer

A Crystal Ball for Prostate Cancer Treatment

IRP’s Dr. Adam Sowalsky Looks to Tumors’ Origins to Predict Outcomes

crystal ball

"Skate to where the puck is going, not where it has been." — hockey great Wayne Gretzky

Imagine two men, both diagnosed with prostate cancer. For one, the disease will remain a quiet shadow, never seriously threatening his life. For the other, it will become an aggressive adversary, resisting treatments and altering his future. This June, as Men's Health Month brings such realities into focus, a critical question echoes in clinics and labs: how can we identify early on which cancer will turn dangerous, and how can we use that knowledge to change a patient's outcome for the better? 

IRP senior investigator Adam G. Sowalsky, Ph.D., believes the answer lies not just in how cancer adapts during treatment, but in the evolutionary traits it already possesses when it first emerges. 

Poster Session Showcases IRP Graduate Students

Event Includes In-Person Presentations for First Time Since 2020

people looking at posters at the 2023 NIH Graduate Student Research Symposium poster session

Three years after COVID-19 dramatically changed the way scientists and many others work, much of life in the NIH IRP has begun to resemble the way things were in February of 2020. This includes the return of in-person scientific poster sessions like the one that took place on February 16 as part of the 19th annual NIH Graduate Student Research Symposium. Nearly 130 graduate students conducting their Ph.D. research in IRP labs as part of NIH’s Graduate Partnership Program presented their progress at that poster session and its virtual counterpart held February 15.

The two poster sessions made it clear that IRP graduate students are essential contributors to the life-changing discoveries made at NIH, from using geckos to learn about human eye diseases to investigating how the immune system combats infectious invaders to exploring ways to improve cancer treatment. Keep reading to learn about some of the bright scientists-in-training who showed off their work during the two-day event.

African Ancestry May Influence Immune Response to Prostate Cancer

IRP Study Could Help Explain Racial Disparities in Disease Outcomes

black man getting blood drawn by nurses

Even as advances in therapy are extending the lives of many cancer patients, there are still stark differences in how likely patients of different races and ethnicities are to die from the disease. A recent IRP study suggests that a weaker immune response against cancer could explain the worse clinical outcomes for Black men with prostate cancer, pointing to potential strategies that could help close this gap.

Inflammation Contributes to Cancer-Related Fatigue

Mouse Study Suggests Approach to Combat Patients’ Debilitating Tiredness

exhausted person in bed

The human body is like any delicate ecosystem — disrupting just one part of it can have unexpected, widespread repercussions. Cancer patients know this well, not just because a tumor confined to one organ can cause a range of symptoms, but also because radiation treatment aimed specifically at the tumor sometimes leaves patients feeling utterly exhausted. New IRP research suggests that an inflammatory response to targeted radiation therapy is responsible for this common side effect of the treatment.

IRP’s Peter Choyke Elected to National Academy of Medicine

New Imaging Approach Improves Care for Men at Risk of Prostate Cancer

Dr. Peter Choyke

The National Academy of Medicine (NAM), first established in 1970 by the National Academy of Sciences as the Institute of Medicine (IOM), is comprised of more than 2,000 elected members from around the world who provide scientific and policy guidance on important matters relating to human health. Election to the NAM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have not only made critical scientific discoveries but have also demonstrated a laudable commitment to public service.

IRP senior investigator Peter Choyke, M.D., was elected to the NAM last year for his pioneering advances in imaging technologies for prostate cancer, which have improved diagnosis and treatment. Dr. Choyke, who directs the Molecular Imaging Branch at the National Cancer Institute (NCI), harnessed artificial intelligence to superimpose images from magnetic resonance imaging (MRI) scans onto images taken in real time using ultrasound, thereby enhancing doctors’ ability to non-invasively examine prostate tumors. This allows doctors to be more precise with their biopsies, thereby lowering discomfort and the risk of nerve damage when they take samples of the tumor. Better yet, if the images show no signs of cancer, patients can skip the invasive biopsy procedure entirely and just continue regular monitoring and checkups.

Technology Incubators and Imaging at NIH Research Festival

Until recently, visualizing many of the processes underlying human diseases had been almost impossible. The NIH IRP’s role in developing technologies that can peer into human organs and cells is a key component of the Long-Term Intramural Research Program Planning Report and basis of sessions during this year’s #ResearchFest.